Icon

XENLETA (nda211672)- (EQ 600MG BASE)

LEFAMULIN ACETATE NABRIVA
EQ 600MG BASE
No No
2031-May-23 2024-Aug-19
None None
2029-Aug-19 No
XENLETA is a pleuromutilin antibacterial indicated for the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 600MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.